Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $29.68 in the prior trading day, Dyne Therapeutics Inc (NASDAQ: DYN) closed at $29.99, up 1.04%. In other words, the price has increased by $1.04 from its previous closing price. On the day, 1.09 million shares were traded. DYN stock price reached its highest trading level at $30.28 during the session, while it also had its lowest trading level at $28.795.
Ratios:
Our goal is to gain a better understanding of DYN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.02 and its Current Ratio is at 17.02. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on October 24, 2024, Downgraded its rating to Neutral and sets its target price to $35 from $43 previously.
On May 21, 2024, Chardan Capital Markets reiterated its Buy rating and also lowered its target price recommendation from $31 to $42.
On April 30, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $40.Morgan Stanley initiated its Overweight rating on April 30, 2024, with a $40 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 18 ’24 when Incerti Carlo sold 16,500 shares for $28.73 per share. The transaction valued at 474,045 led to the insider holds 0 shares of the business.
Rhodes Jason P sold 782 shares of DYN for $25,884 on Nov 14 ’24. The Director now owns 15,962 shares after completing the transaction at $33.10 per share. On Nov 18 ’24, another insider, Incerti Carlo, who serves as the Director of the company, bought 16,500 shares for $28.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DYN now has a Market Capitalization of 3051962368 and an Enterprise Value of 2353145088.
Stock Price History:
Over the past 52 weeks, DYN has reached a high of $47.45, while it has fallen to a 52-week low of $10.03. The 50-Day Moving Average of the stock is -7.19%, while the 200-Day Moving Average is calculated to be -7.22%.
Shares Statistics:
The stock has traded on average 1.27M shares per day over the past 3-months and 1303930 shares per day over the last 10 days, according to various share statistics. A total of 101.77M shares are outstanding, with a floating share count of 77.01M. Insiders hold about 24.33% of the company’s shares, while institutions hold 86.86% stake in the company. Shares short for DYN as of 1730332800 were 9943878 with a Short Ratio of 7.80, compared to 1727654400 on 8879434. Therefore, it implies a Short% of Shares Outstanding of 9943878 and a Short% of Float of 11.790000000000001.
